SYNOPSIS: SYNthesize and OPtimize System in Silico
- PMID: 12801239
- DOI: 10.1021/jm030809x
SYNOPSIS: SYNthesize and OPtimize System in Silico
Abstract
We present a de novo design program called SYNOPSIS, that includes a synthesis route for each generated molecule. SYNOPSIS designs novel molecules by starting from a database of available molecules and simulating organic synthesis steps. This way of generating molecules imposes synthetic accessibility on the molecules. In addition to a starting database, a fitness function is needed that calculates the value of a desired property for an arbitrary molecule. The values obtained from this function guide the design process in optimizing the molecules toward an optimal value of the calculated property. Two applications are described. The first uses an electric dipole moment calculation to generate molecules possessing a strong dipole moment. The second makes use of the three-dimensional structure of a viral enzyme in order to generate high affinity ligands. Twenty eight compounds designed with the program resulted in 18 synthesized and tested compounds, 10 of which showed HIV inhibitory activity in vitro.
Similar articles
-
LEA3D: a computer-aided ligand design for structure-based drug design.J Med Chem. 2005 Apr 7;48(7):2457-68. doi: 10.1021/jm0492296. J Med Chem. 2005. PMID: 15801836
-
3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.Bioorg Med Chem Lett. 2008 Feb 1;18(3):1181-94. doi: 10.1016/j.bmcl.2007.11.134. Epub 2007 Dec 8. Bioorg Med Chem Lett. 2008. PMID: 18155520
-
Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.Chem Biol Drug Des. 2008 Nov;72(5):350-9. doi: 10.1111/j.1747-0285.2008.00713.x. Chem Biol Drug Des. 2008. PMID: 19012571
-
Assessment of structural diversity in combinatorial synthesis.Curr Opin Chem Biol. 2005 Jun;9(3):304-9. doi: 10.1016/j.cbpa.2005.03.004. Curr Opin Chem Biol. 2005. PMID: 15939333 Review.
-
De novo drug design.Methods Mol Biol. 2011;672:299-323. doi: 10.1007/978-1-60761-839-3_12. Methods Mol Biol. 2011. PMID: 20838974 Review.
Cited by
-
ReMODE: a deep learning-based web server for target-specific drug design.J Cheminform. 2022 Dec 12;14(1):84. doi: 10.1186/s13321-022-00665-w. J Cheminform. 2022. PMID: 36510307 Free PMC article.
-
Template-based de novo design for type II kinase inhibitors and its extented application to acetylcholinesterase inhibitors.Molecules. 2013 Oct 31;18(11):13487-509. doi: 10.3390/molecules181113487. Molecules. 2013. PMID: 24184819 Free PMC article.
-
SAVI, in silico generation of billions of easily synthesizable compounds through expert-system type rules.Sci Data. 2020 Nov 11;7(1):384. doi: 10.1038/s41597-020-00727-4. Sci Data. 2020. PMID: 33177514 Free PMC article.
-
Parallel tempered genetic algorithm guided by deep neural networks for inverse molecular design.Digit Discov. 2022 May 3;1(4):390-404. doi: 10.1039/d2dd00003b. eCollection 2022 Aug 8. Digit Discov. 2022. PMID: 36091415 Free PMC article.
-
Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple).ACS Cent Sci. 2018 Feb 28;4(2):180-188. doi: 10.1021/acscentsci.7b00401. Epub 2018 Feb 7. ACS Cent Sci. 2018. PMID: 29532017 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical